These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
80 related items for PubMed ID: 23181280
1. The impact of doxorubicin and dexrazoxane injection of prepubertal female rats on pregnancy outcome and cardiac function postpartum. Calvé A, Noiles W, Sebag IA, Chalifour LE. Can J Physiol Pharmacol; 2012 Nov; 90(11):1527-34. PubMed ID: 23181280 [Abstract] [Full Text] [Related]
2. Cardiac response to doxorubicin and dexrazoxane in intact and ovariectomized young female rats at rest and after swim training. Calvé A, Haddad R, Barama SN, Meilleur M, Sebag IA, Chalifour LE. Am J Physiol Heart Circ Physiol; 2012 May 15; 302(10):H2048-57. PubMed ID: 22447943 [Abstract] [Full Text] [Related]
5. Dexrazoxane protects against doxorubicin-induced cardiomyopathy: upregulation of Akt and Erk phosphorylation in a rat model. Xiang P, Deng HY, Li K, Huang GY, Chen Y, Tu L, Ng PC, Pong NH, Zhao H, Zhang L, Sung RY. Cancer Chemother Pharmacol; 2009 Jan 15; 63(2):343-9. PubMed ID: 18379782 [Abstract] [Full Text] [Related]
8. Cardiac structure/function, protein expression, and DNA methylation are changed in adult female mice exposed to diethylstilbestrol in utero. Haddad R, Kasneci A, Sebag IA, Chalifour LE. Can J Physiol Pharmacol; 2013 Sep 15; 91(9):741-9. PubMed ID: 23984849 [Abstract] [Full Text] [Related]
9. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice. Marsman D. Toxic Rep Ser; 1995 Apr 15; 30():1-G5. PubMed ID: 12209194 [Abstract] [Full Text] [Related]
11. Rehabilitative exercise in a rat model of doxorubicin cardiotoxicity. Hydock DS, Lien CY, Jensen BT, Parry TL, Schneider CM, Hayward R. Exp Biol Med (Maywood); 2012 Dec 15; 237(12):1483-92. PubMed ID: 23354407 [Abstract] [Full Text] [Related]
12. Excess of glucocorticoid induces myocardial remodeling and alteration of calcium signaling in cardiomyocytes. De P, Roy SG, Kar D, Bandyopadhyay A. J Endocrinol; 2011 Apr 15; 209(1):105-14. PubMed ID: 21282255 [Abstract] [Full Text] [Related]
15. Kaempferol protects against doxorubicin-induced cardiotoxicity in vivo and in vitro. Xiao J, Sun GB, Sun B, Wu Y, He L, Wang X, Chen RC, Cao L, Ren XY, Sun XB. Toxicology; 2012 Feb 06; 292(1):53-62. PubMed ID: 22155320 [Abstract] [Full Text] [Related]
16. Dexrazoxane pre-treatment protects skinned rat cardiac trabeculae against delayed doxorubicin-induced impairment of crossbridge kinetics. de Beer EL, Bottone AE, van Rijk MC, van der Velden J, Voest EE. Br J Pharmacol; 2002 Apr 06; 135(7):1707-14. PubMed ID: 11934811 [Abstract] [Full Text] [Related]
19. Cardioprotection by dexrazoxane in rats treated with doxorubicin and paclitaxel. Della Torre P, Imondi AR, Bernardi C, Podestà A, Moneta D, Riflettuto M, Mazué G. Cancer Chemother Pharmacol; 1999 Apr 06; 44(2):138-42. PubMed ID: 10412948 [Abstract] [Full Text] [Related]
20. Dexrazoxane's protection of jejunal crypt cells in the jejunum of C3Hf/Kam mice from doxorubicin-induced toxicity. Pearlman M, Jendiroba D, Pagliaro L, Keyhani A, Liu B, Freireich EJ, Travis E. Cancer Chemother Pharmacol; 2003 Dec 06; 52(6):477-81. PubMed ID: 12827292 [Abstract] [Full Text] [Related] Page: [Next] [New Search]